APTINYX INC's ticker is APTX and the CUSIP is 03836N103. A total of 44 filers reported holding APTINYX INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $7,000 | -98.7% | 13,100 | -94.4% | 0.00% | – |
| Q1 2022 | $531,000 | -59.2% | 233,770 | -52.0% | 0.00% | – |
| Q4 2021 | $1,300,000 | +258.1% | 486,550 | +213.6% | 0.00% | – |
| Q3 2021 | $363,000 | +59.2% | 155,134 | +92.5% | 0.00% | – |
| Q2 2021 | $228,000 | +130.3% | 80,581 | +144.5% | 0.00% | – |
| Q1 2021 | $99,000 | -73.9% | 32,955 | -70.0% | 0.00% | – |
| Q4 2020 | $380,000 | +13.1% | 109,704 | -29.5% | 0.00% | – |
| Q1 2020 | $336,000 | +546.2% | 155,612 | +918.8% | 0.00% | – |
| Q4 2019 | $52,000 | – | 15,274 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 3,290,079 | $1,836,000 | 1.19% |
| ADAMS STREET PARTNERS LLC | 5,395,996 | $3,010,000 | 0.78% |
| Bain Capital Life Sciences Investors, LLC | 8,891,758 | $4,961,000 | 0.58% |
| Artal Group S.A. | 6,116,493 | $3,412,000 | 0.18% |
| Frazier Life Sciences Management, L.P. | 1,883,244 | $1,051,000 | 0.10% |
| NORTHWESTERN UNIVERSITY | 109,280 | $61,000 | 0.06% |
| DCF Advisers, LLC | 48,529 | $27,000 | 0.02% |
| Meridian Wealth Management, LLC | 192,000 | $107,000 | 0.01% |
| Orbimed Advisors | 538,500 | $300,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 157,641 | $88,000 | 0.00% |